Top Global Biopharmas Standardize on
³Ô¹Ï±¬ÁÏ China CRM Suite
6 of the top 20 biopharmas have chosen ³Ô¹Ï±¬ÁÏ for China-specific CRM
PLEASANTON, CA and SHANGHAI, China ¡ª March 3, 2025 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced that 6 of the top 20 biopharmas have now chosen ³Ô¹Ï±¬ÁÏ China CRM Suite to advance healthcare professional (HCP) engagement in China. ³Ô¹Ï±¬ÁÏ China CRM Suite is developed in China for China leveraging ³Ô¹Ï±¬ÁÏ¡¯s global development processes for compliance and quality. It includes China-specific requirements and technologies, is hosted in the country, and meets all local privacy and data export requirements.
¡°³Ô¹Ï±¬ÁÏ China CRM Suite is being used by more global biopharmas than any other CRM in China,¡± said Matt Farrell, president, ³Ô¹Ï±¬ÁÏ Commercial Cloud. ¡°We are excited that ³Ô¹Ï±¬ÁÏ China CRM Suite has become the standard for multinational corporations to deliver compliant, customer-centric HCP engagement in China.¡±
³Ô¹Ï±¬ÁÏ China CRM Suite is part of ³Ô¹Ï±¬ÁÏ Commercial Cloud, the global technology foundation for commercial excellence. ³Ô¹Ï±¬ÁÏ China CRM Suite includes China-specific applications to advance customer centricity including China CRM, China Events Management, Approved WeChat, China Engage, and China Campaign Manager. As a global solution, ³Ô¹Ï±¬ÁÏ China CRM Suite works seamlessly with ³Ô¹Ï±¬ÁÏ PromoMats, ³Ô¹Ï±¬ÁÏ Network, and ³Ô¹Ï±¬ÁÏ OpenData.
Additional Information
For more on ³Ô¹Ï±¬ÁÏ China CRM Suite, visit:
About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world¡¯s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at .
Contact:
Alison Borris
³Ô¹Ï±¬ÁÏ Systems, U.S.
alison.borris@veeva.com
Lotus Cai
³Ô¹Ï±¬ÁÏ Systems, China
lotus.cai@veeva.com